Poliovirus-Neutralizing Antibody Seroprevalence and Vaccine Habits in a Vaccine-Derived Poliovirus Outbreak Region in the Democratic Republic of Congo in 2018: The Impact on the Global Eradication Initiative
Megan Halbrook,Adva Gadoth,Patrick Mukadi,Nicole A. Hoff,Kamy Musene,Camille Dzogang,Cyrus Shannon Sinai,D’Andre Spencer,Guillaume Ngoie-Mwamba,Sylvia Tangney,Frank Salet,Michel Nyembwe,Michel Kambamba Nzaji,Merly Tambu,Placide Mbala,Trevon Fuller,Sue K. Gerber,Didine Kaba,Jean Jacques Muyembe-Tamfum,Anne W. Rimoin,D'Andre Spencer
DOI: https://doi.org/10.3390/vaccines12030246
2024-02-28
Vaccines
Abstract:Despite the successes in wild-type polio eradication, poor vaccine coverage in the DRC has led to the occurrence of circulating vaccine-derived poliovirus outbreaks. This cross-sectional population-based survey provides an update to previous poliovirus-neutralizing antibody seroprevalence studies in the DRC and quantifies risk factors for under-immunization and parental knowledge that guide vaccine decision making. Among the 964 children between 6 and 35 months in our survey, 43.8% (95% CI: 40.6–47.0%), 41.1% (38.0–44.2%), and 38.0% (34.9–41.0%) had protective neutralizing titers to polio types 1, 2, and 3, respectively. We found that 60.7% of parents reported knowing about polio, yet 25.6% reported knowing how it spreads. Our data supported the conclusion that polio outreach efforts were successfully connecting with communities—79.4% of participants had someone come to their home with information about polio, and 88.5% had heard of a polio vaccination campaign. Additionally, the odds of seroreactivity to only serotype 2 were far greater in health zones that had a history of supplementary immunization activities (SIAs) compared to health zones that did not. While SIAs may be reaching under-vaccinated communities as a whole, these results are a continuation of the downward trend of seroprevalence rates in this region.
immunology,medicine, research & experimental